Biotech News
Related news
XGNExagen2026-11-10 12:30 EST
Exagen Inc. Reports Third Quarter 2026 Financial Results
XGNExagen2026-10-27 13:00 EST
Exagen to Announce Third Quarter Financial Results on November 10, 2026
ANABAnaptysBio, Inc.2026-11-12 21:15 EST
Anaptys Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
ENTAEnanta Pharmaceuticals2026-11-16 21:01 EST
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2026
HCWBHCW Biologics2026-11-16 13:15 EST
HCW Biologics Reports Third Quarter 2026 Business and Clinical Development Highlights and Financial Results
LUCDLucid Diagnostics2026-11-12 13:00 EST
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2026 Financial Results
OSUROraSure Technologies, Inc.2026-11-09 21:05 EST
OraSure Announces Third Quarter 2026 Financial Results; Strategic Execution Drives Double-Digit Year-Over-Year Growth and Margin Expansion
IMVTImmunovant2026-11-09 12:00 EST
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended September 30, 2026
BIAFbioAffinity Technologies, Inc.2026-11-06 22:40 EST
bioAffinity Technologies Reports Third Quarter 2026 Results and Continued Momentum in CyPath® Lung Commercialization
SNGXSOLIGENIX2026-11-06 12:30 EST
Soligenix Announces Recent Updates and Third Quarter 2026 Financial Results
Exagen
Autoimmune Diagnostics Exagen provides diagnostic testing for autoimmune and rheumatic diseases. Its tests are designed to help clinicians resolve diagnostically complex cases and support ongoing disease management. AVISE CTD AVISE CTD is the company's flagship testing service for lupus and other connective-tissue diseases. It combines...
Recent company news
XGNExagen2026-11-10 12:30 EST
Exagen Inc. Reports Third Quarter 2026 Financial Results
XGNExagen2026-10-29 13:00 EST
Exagen Inc. to Participate in Upcoming Investor Conferences
XGNExagen2026-10-27 13:00 EST
Exagen to Announce Third Quarter Financial Results on November 10, 2026
XGNExagen2026-08-04 12:00 EST
Exagen Inc. Reports Second Quarter 2026 Financial Results
XGNExagen2026-07-28 13:00 EST
Exagen Inc. to Participate in Upcoming Investor Conference
Stock data
- Close
- 3.80 USD
- Market cap
- 116.45M USD
- Exchange
- NASDAQ
- Sector
- MedTech
- Location
- United States
